Evidence map›Paper›PMID 34684215›Full record

ArticlePathogens (Basel, Switzerland)2021

Coronavirus Disease 2019 on the Heels of Ebola Virus Disease in West Africa.

Zygmunt F Dembek, Kierstyn T Schwartz-Watjen, Anna L Swiatecka, Katherine M Broadway, Steven J Hadeed, Jerry L Mothershead, Tesema Chekol, Akeisha N Owens, Aiguo Wu

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zygmunt F DembekBattelle Memorial Institute, Support to DTRA Technical Reachback, Columbus, OH 43201, USA.
Kierstyn T Schwartz-WatjenApplied Research Associates (ARA), Support to DTRA Technical Reachback, Albuquerque, NM 87110, USA.ORCID 0000-0002-5000-0370
Anna L SwiateckaBattelle Memorial Institute, Support to DTRA Technical Reachback, Columbus, OH 43201, USA.
Katherine M BroadwayDefense Sciences, Inc. (DSI), Support to DTRA Technical Reachback, San Antonio, TX 78230, USA.
Steven J HadeedBattelle Memorial Institute, Support to DTRA Technical Reachback, Columbus, OH 43201, USA.
Jerry L MothersheadApplied Research Associates (ARA), Support to DTRA Technical Reachback, Albuquerque, NM 87110, USA.
Tesema ChekolBattelle Memorial Institute, Support to DTRA Technical Reachback, Columbus, OH 43201, USA.
Akeisha N OwensDefense Threat Reduction Agency (DTRA), Fort Belvoir, VA 22060, USA.
Aiguo WuDefense Threat Reduction Agency (DTRA), Fort Belvoir, VA 22060, USA.
Battelle · USApplied Research Associates (United States) · USDefense Threat Reduction Agency · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study utilized modeling and simulation to examine the effectiveness of current and potential future COVID-19 response interventions in the West African countries of Guinea, Liberia, and Sierra Leone. A comparison between simulations can highlight which interventions could have an effect on the pandemic in these countries. An extended compartmental model was used to run simulations incorporating multiple vaccination strategies and non-pharmaceutical interventions (NPIs). In addition to the customary categories of susceptible, exposed, infected, and recovered (SEIR) compartments, this COVID-19 model incorporated early and late disease states, isolation, treatment, and death. Lessons learned from the 2014-2016 Ebola virus disease outbreak-especially the optimization of each country's resource allocation-were incorporated in the presented models. For each country, models were calibrated to an estimated number of infections based on actual reported cases and deaths. Simulations were run to test the potential future effects of vaccination and NPIs. Multiple levels of vaccination were considered, based on announced vaccine allocation plans and notional scenarios. Increased vaccination combined with NPI mitigation strategies resulted in thousands of fewer COVID-19 infections in each country. This study demonstrates the importance of increased vaccinations. The levels of vaccination in this study would require substantial increases in vaccination supplies obtained through national purchases or international aid. While this study does not aim to develop a model that predicts the future, it can provide useful information for decision-makers in low- and middle-income nations. Such information can be used to prioritize and optimize limited available resources for targeted interventions that will have the greatest impact on COVID-19 pandemic response.

Indexed as

coronavirus disease 2019 (COVID-19) pandemicdecision makingEbola outbreaknon-pharmaceutical interventions (NPIs)susceptible–exposed–infected–recovered (SEIR) modelsvaccination

Identifiers

PMID34684215
PMCPMC8537256
OpenAlexW3203751122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.